These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22108488)

  • 1. Assessment of nutraceuticals and food supplements.
    Belcaro G; Cornelli U; Ledda A; Hosoi M
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):I-II. PubMed ID: 22108488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rational use of dietary supplements and nutraceuticals in clinical medicine.
    Mechanick JI
    Mt Sinai J Med; 2005 May; 72(3):161-5. PubMed ID: 15915310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quality of commercially available nutraceutical supplements and food sources.
    Lockwood GB
    J Pharm Pharmacol; 2011 Jan; 63(1):3-10. PubMed ID: 21155809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Legislation relating to nutraceuticals in the European Union with a particular focus on botanical-sourced products.
    Gulati OP; Berry Ottaway P
    Toxicology; 2006 Apr; 221(1):75-87. PubMed ID: 16487647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interference of botanicals and nutraceuticals with the effects of antithrombotic agents: how should the available evidence be weighed?
    De Smet PA
    Thromb Res; 2005; 117(1-2):19-24; discussion 39-42. PubMed ID: 16239022
    [No Abstract]   [Full Text] [Related]  

  • 6. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
    Coppens P; da Silva MF; Pettman S
    Toxicology; 2006 Apr; 221(1):59-74. PubMed ID: 16469424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary supplements and related products: a brief summary.
    Rapaka RS; Coates PM
    Life Sci; 2006 Mar; 78(18):2026-32. PubMed ID: 16497339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutraceuticals: miracle or meme?
    Ridinger MH
    Clin Pharmacol Ther; 2007 Oct; 82(4):352-6. PubMed ID: 17851571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease.
    Houston MC
    Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):165-83. PubMed ID: 20400494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial strategies employing nutraceuticals for cancer development.
    Shukla Y; George J
    Ann N Y Acad Sci; 2011 Jul; 1229():162-75. PubMed ID: 21793852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects.
    Cicero AF; Ferroni A; Ertek S
    Expert Opin Drug Saf; 2012 Sep; 11(5):753-66. PubMed ID: 22788832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory aspects of diets, supplements, and nutraceuticals.
    Dzanis DA
    Clin Tech Small Anim Pract; 1998 Nov; 13(4):193-6. PubMed ID: 9842110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutraceuticals in cardiovascular prevention: lessons from studies on endothelial function.
    Zuchi C; Ambrosio G; Lüscher TF; Landmesser U
    Cardiovasc Ther; 2010 Aug; 28(4):187-201. PubMed ID: 20553294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety assurances for dietary supplements policy issues and new research paradigms.
    Basch EM; Servoss JC; Tedrow UB
    J Herb Pharmacother; 2005; 5(1):3-15. PubMed ID: 16093231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional foods and dietary supplements: products at the interface between pharma and nutrition.
    Eussen SR; Verhagen H; Klungel OH; Garssen J; van Loveren H; van Kranen HJ; Rompelberg CJ
    Eur J Pharmacol; 2011 Sep; 668 Suppl 1():S2-9. PubMed ID: 21816140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH; Street DA; O'Neill RK
    Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of dietary supplements with antithrombotic agents: scope of the problem.
    Marder VJ
    Thromb Res; 2005; 117(1-2):7-13; discussion 39-42. PubMed ID: 16076481
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety assessment of plant food supplements (PFS).
    van den Berg SJ; Serra-Majem L; Coppens P; Rietjens IM
    Food Funct; 2011 Dec; 2(12):760-8. PubMed ID: 21804969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An approach to evaluating drug-nutrient interactions.
    Santos CA; Boullata JI
    Pharmacotherapy; 2005 Dec; 25(12):1789-800. PubMed ID: 16305298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.